AI assistant
Sending…
DAVITA INC. — Director's Dealing 2011
Mar 1, 2011
30643_dirs_2011-03-01_ae43df93-0b5a-426a-8f0d-ce18b064e1bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA INC (DVA)
CIK: 0000927066
Period of Report: 2011-02-25
Reporting Person: Nissenson Allen (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-25 | Common Stock | M | 4000 | $56.14 | Acquired | 4925 | Direct |
| 2011-02-25 | Common Stock | F | 2897 | $77.52 | Disposed | 2028 | Direct |
| 2011-02-25 | Common Stock | S | 1103 | $78.50 | Disposed | 925 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-25 | Stock Appreciation Right | $56.14 | M | 4000 | Disposed | 2013-08-01 | Common Stock (4000) | Direct |
Footnotes
F1: Includes 425 shares purchased in accordance with the 2010 Employee Stock Purchase Program.
F2: Stock Appreciation Right, pursuant to the 2002 Equity Compensation Plan, which vest 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every 4 months thereafter.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25